6.83
price up icon1.64%   0.11
after-market 시간 외 거래: 6.83
loading
전일 마감가:
$6.72
열려 있는:
$6.8
하루 거래량:
851.32K
Relative Volume:
0.73
시가총액:
$366.38M
수익:
$1.02B
순이익/손실:
$-757.20M
주가수익비율:
-0.4627
EPS:
-14.76
순현금흐름:
$-257.90M
1주 성능:
+8.24%
1개월 성능:
+6.72%
6개월 성능:
-18.88%
1년 성능:
+4.12%
1일 변동 폭
Value
$6.69
$6.95
1주일 범위
Value
$6.15
$6.98
52주 변동 폭
Value
$4.02
$15.10

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
명칭
Emergent Biosolutions Inc
Name
전화
240-631-3200
Name
주소
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
직원
900
Name
트위터
@emergentbiosolu
Name
다음 수익 날짜
2025-03-03
Name
최신 SEC 제출 서류
Name
EBS's Discussions on Twitter

EBS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
6.83 366.38M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
20.19 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.79 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.42 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.06 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.56 20.17B 16.54B -1.64B 749.00M -1.45

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-30 개시 H.C. Wainwright Buy
2024-08-22 개시 Rodman & Renshaw Buy
2024-03-07 업그레이드 The Benchmark Company Hold → Buy
2023-11-20 재개 JP Morgan Underweight
2023-08-29 다운그레이드 The Benchmark Company Buy → Hold
2023-04-10 업그레이드 The Benchmark Company Hold → Buy
2023-03-17 다운그레이드 JP Morgan Neutral → Underweight
2022-11-10 다운그레이드 The Benchmark Company Buy → Hold
2022-04-29 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2022-01-20 업그레이드 The Benchmark Company Hold → Buy
2021-11-08 다운그레이드 The Benchmark Company Buy → Hold
2021-05-05 다운그레이드 Argus Buy → Hold
2021-04-07 개시 The Benchmark Company Buy
2021-02-24 업그레이드 Chardan Capital Markets Neutral → Buy
2021-02-19 다운그레이드 Chardan Capital Markets Buy → Neutral
2021-01-08 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-09-14 재개 JP Morgan Neutral
2020-07-31 재확인 Chardan Capital Markets Buy
2019-09-12 개시 Guggenheim Buy
2019-09-04 업그레이드 Wells Fargo Market Perform → Outperform
2018-11-02 업그레이드 Goldman Neutral → Buy
2018-08-03 재확인 Chardan Capital Markets Buy
2018-06-13 개시 Argus Buy
2018-04-25 다운그레이드 Wells Fargo Outperform → Market Perform
2018-01-24 개시 Goldman Neutral
2018-01-16 재확인 Chardan Capital Markets Buy
2016-06-28 재확인 Singular Research Buy
2016-04-15 개시 Chardan Capital Markets Buy
2016-03-28 개시 Singular Research Buy
2016-02-19 개시 Wells Fargo Outperform
2014-05-15 개시 Summer Street Research Buy
2011-05-31 재확인 WBB Securities Strong Buy
2011-01-10 재확인 Wedbush Outperform
2010-11-05 재확인 Wedbush Outperform
2010-08-18 업그레이드 WBB Securities Buy → Strong Buy
2010-08-06 재확인 Caris & Company Buy
모두보기

Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스

pulisher
Jun 16, 2025

Government Contract Update: $62M payment to EMERGENT BIOSOLUTIONS CANADA INC - Nasdaq

Jun 16, 2025
pulisher
Jun 12, 2025

BRIEF—LigaChem links up with NovaRock - The Pharma Letter

Jun 12, 2025
pulisher
Jun 07, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact Its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO’s Insider Sales - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions at Jefferies Conference: Strategic Transformation By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Squarepoint Ops LLC Has $451,000 Stake in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions (EBS) Partners with Foundation for Opioid Awareness | EBS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions Supports Victoria's Voice Foundation's Nat - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies | EBS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Breaking: Dramatic 34% Drop in US Opioid Deaths as Emergent Expands Life-Saving Naloxone Access - Stock Titan

Jun 05, 2025
pulisher
Jun 03, 2025

Vaccine Contract Manufacturing Market Set to Witness - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Biodefense Market Set to Witness Significant GrowthEmergent BioSolutions Inc., SIGA Technologies - openPR.com

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Boosts Stake in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Investors Can Still File Late Claims in Emergent BioSolutions Settlement - TradingView

May 30, 2025
pulisher
May 28, 2025

Northern Trust Corp Acquires 3,692 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

May 28, 2025
pulisher
May 26, 2025

Emergent BioSolutions discloses CEO stock purchase - MSN

May 26, 2025
pulisher
May 23, 2025

Emergent Biosolutions Settlement Receives Preliminary Approval - TipRanks

May 23, 2025
pulisher
May 21, 2025

Emergent BioSolutions at RBC Conference: Strategic Turnaround Focus By Investing.com - Investing.com India

May 21, 2025
pulisher
May 19, 2025

Emergent BioSolutions ($EBS) Is Paying a $40M Settlement to Investors — Here’s How to Get Your Share - TradingView

May 19, 2025
pulisher
May 19, 2025

Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions - Yahoo Finance

May 19, 2025
pulisher
May 18, 2025

Q1 EPS Forecast for Emergent BioSolutions Lowered by Analyst - Defense World

May 18, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge 9.7% Following Positive Developments | EBS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) CEO Increases Stake with $350,000 Sh - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 13% | EBS Stock Ne - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 14% | EBS Stock Ne - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 14% | EBS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions (EBS) Shares Surge Over 13% | EBS Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Emergent BioSolutions stock up on insider purchase (EBS:NYSE) - Seeking Alpha

May 16, 2025
pulisher
May 16, 2025

Insider Buying: Joseph Papa Acquires 60,000 Shares of Emergent B - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Insider Buying: Joseph Papa Acquires 60,000 Shares of Emergent BioSolutions Inc (EBS) - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Emergent BioSolutions to Participate in Upcoming Investor Conferences | EBS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Emergent BioSolutions to Participate in Upcoming Investor Conferences - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Emergent BioSolutions Lines Up 4 Major Wall Street Conferences: RBC, Goldman Sachs, Jefferies Featured - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Sells 11,665 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

May 13, 2025
pulisher
May 11, 2025

Emergent BioSolutions Inc.'s (NYSE:EBS) Share Price Boosted 29% But Its Business Prospects Need A Lift Too - simplywall.st

May 11, 2025
pulisher
May 09, 2025

Emergent BioSolutions (EBS) Q1 2025 Earnings Highlight Turnaroun - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Emergent Biosolutions Q1 2025 Earnings Preview - MSN

May 09, 2025
pulisher
May 09, 2025

Emergent BioSolutions Inc. (NYSE:EBS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - MSN

May 08, 2025
pulisher
May 08, 2025

Emergent biosolutions reaffirms 2025 revenue guidance of $750M-$850M amid turnaround progress - MSN

May 08, 2025
pulisher
May 08, 2025

Emergent Biosolutions: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 08, 2025

Emergent BioSolutions Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... - Yahoo

May 08, 2025
pulisher
May 08, 2025

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid Revenue Challenges - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Earnings call transcript: Emergent BioSolutions Q1 2025 sees 656% net income rise - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Emergent Biosolutions earnings beat by $0.22, revenue fell short of estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Emergent Biosolutions Q1 2025 slides: turnaround progress drives profitability By Investing.com - Investing.com India

May 07, 2025

Emergent Biosolutions Inc (EBS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$14.30
price up icon 3.92%
$9.12
price up icon 2.59%
$126.71
price down icon 0.84%
$284.09
price down icon 0.66%
drug_manufacturers_specialty_generic RDY
$15.33
price down icon 1.10%
$16.56
price down icon 2.59%
자본화:     |  볼륨(24시간):